---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-296686"
form_type: "8-K"
ticker: "NTLA"
cik: "0001652130"
company_name: "Intellia Therapeutics, Inc."
filed_at: "2022-12-01T23:59:59+00:00"
generated_at: "2026-06-21T10:55:47.726210+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Intellia raises ~$293.5M in public offering of 6.55M shares at $45.80

## Summary
- Offering of 6,550,219 shares of common stock at $45.80 per share; underwriter option for up to 982,532 additional shares.
- Net proceeds estimated at $293.5M after underwriting discount and expenses; expected close December 2, 2022.
- Underwriting agreement with Goldman Sachs & Co. LLC; customary representations and indemnification provisions.
- Offering conducted under existing shelf registration statement (File No. 333-251022); prospectus supplement dated November 30, 2022.

## SEC filing metadata
- accession: 0001193125-22-296686
- form_type: 8-K
- ticker: NTLA
- cik: 0001652130
- company_name: Intellia Therapeutics, Inc.
- filed_at: 2022-12-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1652130/000119312522296686/0001193125-22-296686-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1652130/000119312522296686/d358556d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-296686
- JSON: https://secwatch.observer/filing/0001193125-22-296686.json
- Plain text: https://secwatch.observer/filing/0001193125-22-296686.txt

## Key facts
- Material Agreements
  Intellia Therapeutics, Inc. entered into Underwriting Agreement with Goldman Sachs & Co. LLC valued at approximately $293.5 million (effective 2022-11-30).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Goldman Sachs & Co. LLC
  - Value: approximately $293.5 million
  - Effective: 2022-11-30
  source text: On November 30, 2022, Intellia Therapeutics, Inc. (the “Company” or “Intellia”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC (the “Underwriter”), related to a public offering (the “Offering”) of 6,550,219 shares of common stock of the Company, par value $0.0001 per share (the “Common Stock”) at a price to the public of $45.80 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1652130/000119312522296686/0001193125-22-296686-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.